K. Carter Blanton, PA-C

K. Carter Blanton, PA-C

Biographic:

Born: June 23, 1972

Address:

Business: Dermatology Associates of Knoxville, PC
939 Emerald Ave., Suite 705
Knoxville, Tennessee 37917
July, 2004-Present

11416 Grigsby Chapel Road
Suite 100
Knoxville, Tennessee 37934
July, 2004-Present

7557 Dannaher Way, Suite G20
Powell, TN 37849
July, 2004-Present

Previous Employment :

Phoebe Putney Memorial Hospital
Center for Infectious Diseases
January, 2002-July, 2004

Radiology Associates of Valdosta, P.C.
Valdosta, Georgia
1992-1999

Education:

Emory University School of Medicine
Atlanta, Georgia
Physician Assistant, Master of Medical
Science
August ,1999-December, 2001

Valdosta State University
Valdosta, Georgia
B.S. Biology 1996

Professional Licensure and Certification:

Advanced Cardiac Life Support
Board Certified National Commission on
Certification of Physician Assistants
2001

Tennessee Board of Medical Examiners
Committee on Physician Assistants
2004

Affiliations and Organizations:

Emory University Allied Health Honor Council

Fellow Member of the American Academy of
Physician Assistants (AAPA)

Current duties:

See patients daily in an outpatient high volume clinic practice. Evaluation, diagnosis and treatment of a wide variety of skin conditions and diseases, both acute and chronic. Procedures include shave and punch biopsies, D and C, cryotherapy and minor surgical procedures. Hospital consults are performed for dermatological conditions and diseases.

Research Experience:

A Phase 4, Double-Blind, Multicenter, Randomized, Vehicle-Controlled, Cross-
Over Study to Further Evaluate the Risk of Hematological Adverse Events in
G6PD-Deficient Subjects with Acne Vulgaris treated with a Gel.

A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multiple-
Site Study to Evaluate the Clinical Equivalence of Two Shampoos in Patients
with Tinea (Pityriasis) Versicolor.

A Multi-Center, Double-Blind Clinical Comparison of the Efficacy and Safety of
a Topical Gel and Vehicle Gel in the Once Daily Treatment of Acne Vulgaris for
12 Weeks.

A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety
of BID Application of a Topical Cream versus Vehicle in the Treatment of
Psoriasis.

A Randomized, Double-blind, Parallel-group, Vehicle-controlled, Multicenter
Study to Determine the Safety and Therapeutic Equivalence of a Generic
Formulation of a Cream compared to the FDA Approved Cream in the Treatment
of Actinic Keratosis.

A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety
of an Ointment for the Treatment of Atopic Dermatitis

Study of Assessment and Tracking of a Long-term IM Injection for the Treatment
of Adult Patients with Moderate to Severe Psoriasis

A Randomized, Double-blind, Placebo Controlled, Parallel Design, Multiple-site Study to Evaluate the Equivalence of Two Antifungal Creams in Patients with Interdigital Tinea Pedis

A Phase III, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled,
4-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety
of Gels in the Treatment of Moderate to Severe Acne Vulgaris.

A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multi-Site
Clinical Study to Evaluate the Bioequivalence of a Generic Ointment in Patients
with Moderate to Severe Plaque Psoriasis.

A Multi-Center, Randomized, Double-Blind, Parallel-Group Study to Demonstrate the Efficacy and Safety of a Medicated Topical Gel Compared with Two Different Strengths of Medicated Topical Gel and a Topical Gel Vehicle in Subjects with Acne Vulgaris. A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle- Controlled Dose Ranging Clinical Study to Evaluate the Safety and Efficacy of a Topical Cream Applied Twice Daily for 12 Weeks for the Treatment of Facial Acne Vulgaris. A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Demonstrate the Efficacy and Safety of a Lotion Compared With Vehicle Lotion in Subject's with Acne Vulgaris.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WATE. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.